Implementation and use of this guidance may help improve care, clinical outcomes and minimise avoidable medication-related harm.

Included within this document are a range of prescribing indicators and measures to help focus attention and resources on addressing this area. These measures will be of use to individual general practices, general practice clusters, Health and Social Care Partnerships (HSCPs), and health boards. Case studies and examples of what has already been trialled are also included.